Chapter 1 Prefix |
---|
1.1 Market Scope |
1.2 Report Description |
1.3 Research Methodology |
1.3.1 Primary Research |
1.3.2 Secondary Research |
1.3.3 In-house Data Modeling |
Chapter 2 Executive Summary |
---|
Chapter 3 Market Outline |
---|
3.1 Market Inclination, Trend, Outlook and Viewpoint |
3.2 Market Share Analysis: Company’s Competitive Scenario |
3.3 Market Dynamics |
3.3.1 Drivers |
3.3.1.1 Impact Analysis |
3.3.2 Restraints |
3.3.2.1 Impact Analysis |
3.3.3 Opportunities |
Chapter 4 Neurostimulation Devices Market by Device Type: Market Size and Forecast, 2015 – 2024 |
---|
4.1 Overview |
4.2 Implantable Devices |
4.2.1 Current Trend and Analysis |
4.2.2 Market Size and Forecast |
4.2.3 Cochlear Implants |
4.2.4 Cochlear Implants |
4.2.5 Deep Brain Stimulation |
4.2.6 Spinal Cord Stimulation |
4.2.7 Vagus Nerve Stimulation |
4.2.8 Gastric Electric Stimulation |
4.2.9 Others |
4.3 External Devices |
4.3.1 Current Trend and Analysis |
4.3.2 Market Size and Forecast |
4.3.3 Transcranial Magnetic Stimulation (TMS) |
4.3.4 Transcutaneous Electrical Nerve Stimulation (TENS) |
4.3.5 Others |
Chapter 5 Neurostimulation Devices Market by Application: Market Size and Forecast, 2015 – 2024 |
---|
5.1 Overview |
5.2 Parkinson’s Disease |
5.2.1 Current Trend and Analysis |
5.2.2 Market Size and Forecast |
5.3 Pain Management |
5.3.1 Current Trend and Analysis |
5.3.2 Market Size and Forecast |
5.4 Epilepsy |
5.4.1 Current Trend and Analysis |
5.4.2 Market Size and Forecast |
5.5 Hearing Loss |
5.5.1 Current Trend and Analysis |
5.5.2 Market Size and Forecast |
5.6 Gastroparesis |
5.6.1 Current Trend and Analysis |
5.6.2 Market Size and Forecast |
5.7 Urinary and Fecal Incontinence |
5.7.1 Current Trend and Analysis |
5.7.2 Market Size and Forecast |
5.8 Depression |
5.8.1 Current Trend and Analysis |
5.8.2 Market Size and Forecast |
5.9 Others |
5.9.1 Current Trend and Analysis |
5.9.2 Market Size and Forecast |
Chapter 6 Neurostimulation Devices Market by Geography: Market Size and Forecast, 2015 – 2024 |
---|
6.1 Overview |
6.2 North America |
6.2.1 Current Trend and Analysis |
6.2.2 Market Size and Forecast |
6.2.3 US |
6.2.3.1 Market Size and Forecast |
6.2.4 Canada |
6.2.4.1 Market Size and Forecast |
6.2.5 Mexico |
6.2.5.1 Market Size and Forecast |
6.3 Europe |
6.3.1 Current Trend and Analysis |
6.3.2 Market Size and Forecast |
6.3.3 Germany |
6.3.3.1 Market Size and Forecast |
6.3.4 France |
6.3.4.1 Market Size and Forecast |
6.3.5 United Kingdom |
6.3.5.1 Market Size and Forecast |
6.3.6 Others |
6.3.6.1 Market Size and Forecast |
6.4 Asia-Pacific |
6.4.1 Current Trend and Analysis |
6.4.2 Market Size and Forecast |
6.4.3 China |
6.4.3.1 Market Size and Forecast |
6.4.4 India |
6.4.4.1 Market Size and Forecast |
6.4.5 Japan |
6.4.5.1 Market Size and Forecast |
6.4.6 Others |
6.4.6.1 Market Size and Forecast |
6.5 RoW |
6.5.1 Current Trend and Analysis |
6.5.2 Market Size and Forecast |
6.5.3 Middle East |
6.5.3.1 Market Size and Forecast |
6.5.4 South America |
6.5.4.1 Market Size and Forecast |
6.5.5 Africa |
6.5.5.1 Market Size and Forecast |
Chapter 7 Company Profiles |
---|
7.1 DePuy Synthes Companies |
7.2 Cyberonics, Inc. |
7.3 Nevro Corporation |
7.4 St. Jude Medical, Inc. |
7.5 BioControl Medical |
7.6 Synapse Biomedical, Inc. |
7.7 Neuropace, Inc. |
7.8 Boston Scientific Corporation |
7.9 NDI Medical, LLC |
7.10 NeuroSigma, Inc. |